ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.068,21
0,26%
S&P 500
5.473,23
0,77%
Dow Jones
38.778,10
0,49%
Euro vs US Dollar
1,07376
-0,03%
Bitcoin
65.668,30
-1,20%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Verrica Parmaceuticals Inc (VRCA)

  7. Verrica Parmaceuticals Inc (VRCA) News

VRCA

Verrica Parmaceuticals (VRCA)

Verrica Parmaceuticals Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:VRCA
DatumZeitQuelleÜberschriftSymbolFirma
10/06/202422h18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VRCAVerrica Parmaceuticals Inc
07/06/202422h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VRCAVerrica Parmaceuticals Inc
07/06/202422h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VRCAVerrica Parmaceuticals Inc
15/05/202413h45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VRCAVerrica Parmaceuticals Inc
13/05/202422h31Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:VRCAVerrica Parmaceuticals Inc
13/05/202414h01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VRCAVerrica Parmaceuticals Inc
13/05/202413h46Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VRCAVerrica Parmaceuticals Inc
29/02/202414h05Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:VRCAVerrica Parmaceuticals Inc
29/02/202413h45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VRCAVerrica Parmaceuticals Inc
08/01/202414h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VRCAVerrica Parmaceuticals Inc
16/11/202322h49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VRCAVerrica Parmaceuticals Inc
16/11/202322h35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VRCAVerrica Parmaceuticals Inc
16/11/202322h34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VRCAVerrica Parmaceuticals Inc
16/11/202322h33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VRCAVerrica Parmaceuticals Inc
16/11/202322h32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VRCAVerrica Parmaceuticals Inc
16/11/202316h28Edgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NASDAQ:VRCAVerrica Parmaceuticals Inc
15/11/202322h54Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VRCAVerrica Parmaceuticals Inc
15/11/202322h42Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VRCAVerrica Parmaceuticals Inc
15/11/202322h21Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VRCAVerrica Parmaceuticals Inc
15/11/202322h16Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VRCAVerrica Parmaceuticals Inc
15/11/202322h07Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VRCAVerrica Parmaceuticals Inc
09/11/202313h54Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VRCAVerrica Parmaceuticals Inc
09/11/202313h41Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VRCAVerrica Parmaceuticals Inc
28/08/202322h40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VRCAVerrica Parmaceuticals Inc
28/08/202322h39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VRCAVerrica Parmaceuticals Inc
28/08/202322h38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VRCAVerrica Parmaceuticals Inc
28/08/202322h37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VRCAVerrica Parmaceuticals Inc
08/08/202313h52Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VRCAVerrica Parmaceuticals Inc
08/08/202313h40Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VRCAVerrica Parmaceuticals Inc
27/07/202322h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VRCAVerrica Parmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:VRCA

Kürzlich von Ihnen besucht

NYSE
KO
Coca Cola
DBI
MDAX
MDAX
TG
BAYN
Bayer
NYSE
NKE
Nike
USOTC
RHHBY
Roche (QX)
AMEX
XLF
Financial Select Sector
TG
MBG
MercedesBenz
NYSE
DIS
Walt Disney
USOTC
BASFY
BASF (QX)
TG
NOV
Novo Nordisk
COIN
SOLUSD
Solana
DBI
DAX
DAX
TG
RHM
Rheinmetall
NYSE
MCD
McDonalds
FX
EURUSD
Euro vs US Dollar
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten